Drug rebates for insurers tied to higher costs for patients, especially the uninsured

(University of Washington) The study found that rebates were associated with increases in out-of-pocket costs for patients by an average of $6 for those with commercial insurance, $13 for Medicare patients and $39 for the uninsured.